Treatment of COVID-19 with interferon beta-1b — even for just a few days, a much shorter period than is commonly used for maintenance in multiple sclerosis (MS), for example — is associated with ...
The study, published in Blood Advances, looked at patients with an advanced form of acute myeloid leukemia that had grown resistant to other treatments. Their next step was a bone marrow transplant ...
NICE, France — Depression affects up to 50% of patients with chronic hepatitis C virus (HCV) infection receiving treatment with interferon, but it appears to be self-limiting and does not usually ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A single dose of pegylated interferon lambda used as ...
In 1980, TIME Magazine wrote about interferon as the “if” drug for cancer. Promising studies sparked widespread hope around the potential of the interferon to treat cancer, only if it could deliver ...
(MEMPHIS, Tenn. – May 19, 2022) Scientists from St. Jude Children’s Research Hospital have shown that the innate immune sensor, ZBP1, and its associated inflammatory cell death pathway, PANoptosis, ...
Sobi vidareutvecklar Gamifant® (emapalumab) vid gammainterferon-driven sepsis (IDS) baserat på topline-data från EMBRACE (2) ...
"Only Half Of Patients With Multiple Sclerosis Achieve And Maintain Response To Interferon Treatment, Study Shows." ScienceDaily. www.sciencedaily.com / releases / 2008 / 11 / 081110163816.htm ...
Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposide. In a multicenter trial, patients with symptomatic clinical stage ...
Figure 1: The VSV-induced cytopathic effect is visible in human melanoma cells but not in primary human cells with or without interferon-α. Figure 3: VSV inhibits growth of human melanoma xenografts ...
Multiple sclerosis (MS) is a chronic demyelinating disease of the CNS. Between 1987 and 1997, clinical trials of three preparations of recombinant interferon-β were conducted in patients with MS, ...
A small study of an inhaled form of a commonly available drug, interferon beta, suggests it could reduce the odds of patients becoming severely ill. By Benjamin Mueller LONDON — A British drug company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback